Our editorial method
Confidence is not
the same as benefit.
We assess specific claims—not whole supplements. The evidence grade describes confidence; the verdict explains the result, its size and its practical relevance.
01 / Evidence certainty
How much can we trust the answer?
We consider randomisation, blinding, missing data, prespecified outcomes, precision, consistency and relevance to the reader.
02 / Benefit & safety
What does that answer mean?
We separately describe whether benefit is supported, uncertain or not established, how large it is, and the safety considerations.
The letter grades.
High confidence
A substantial body of well-conducted, directly relevant human research gives a consistent, reasonably precise answer. The answer may support benefit or no meaningful benefit.
Moderate confidence
Relevant human trials give a reasonably reliable answer, with limitations that could affect the estimate or its applicability.
Limited confidence
Small studies, imprecision, mixed findings or limited replication leave important uncertainty. A promising signal is not a confident recommendation.
Very low confidence
Serious weaknesses, inconsistency or indirect evidence prevent a reliable estimate. This does not establish that the supplement is ineffective.
Insufficient human evidence
There is not enough suitable human research to assess the specific claim. Mechanisms and animal studies cannot fill that gap.
What a review should make clear.
- The question: formulation, dose, population and outcome.
- The evidence: human trials and syntheses, with sources, dates and study limitations.
- The effect: absolute differences where available, alongside relative results and uncertainty.
- The context: safety, interactions, funding, conflicts and applicability.
How to read a new study.
A meta-analysis does not automatically deserve a high grade. Its reliability depends on the studies included and the methods used. A positive secondary outcome does not erase a negative primary result.
Biomarker changes, animal findings and plausible mechanisms are distinguished from outcomes people can feel or experience. Our reviews are targeted editorial reviews unless explicitly identified as systematic reviews.
Keeping the interpretation honest.
Search scope and review dates should be visible, and meaningful changes to conclusions should be explained. Commercial arrangements should be disclosed separately from evidence assessments. “Pharmacist reviewed” should identify a completed clinical review rather than imply one.